USMLE Step 1 Pharmacology – Female and Transgender Reproductive System & Breast

USMLE provides an outline of the USMLE Step 1 Content. The outline breaks down the exam into systems.  This page will review the female and transgender reproductive system & breast section of the USMLE Step 1 outline as it relates to pharmacology.

Female and Transgender Reproductive System & Breast

Here is a look at a summary of USMLE outline for the female and transgender reproductive system & breast section with a focus on pharmacology related topics.

Breast

• Mastitis

Female Reproductive System

• Bacterial vaginosis
• Candidiasis of the vulva or vagina
• Sexually transmitted infections and exposure
• Cervicitis and endocervicitis
• Genital herpes
• Gonorrhea
• Fitz-Hugh-Curtis syndrome
• Syphilis
• Urethritis
• Vaginitis
• Vulvovaginitis

Fertility and Infertility

• Assisted reproductive techniques
• Contraception
  • Oral contraceptives
  • IUD
  • Vaginal cap
  • Cervical sponge
  • Diaphragm
  • Implants
  • Morning-after pill
  • Male/Female condoms
• Infertility

Menopause

• Perimenopausal menorrhagia
• Vasomotor symptoms
• Postmenopausal atrophic vaginitis

Menstrual and Endocrine Disorders

• Abnormal uterine bleeding
• Dysmenorrhea
• Hirsutism
• Polycystic ovary syndrome
• Premenstrual syndrome

Adverse Effects of Drugs on the Female Reproductive System and Breast

• Antihistamines
• H2-receptor blockers
• Benzodiazepines
• Beta-adrenergic blockers
• Hormone replacement
• Opioids
• Spironolactone
• SSRIs
• Tricyclic antidepressants